Cerity Partners’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,509
Closed -$286K – 3499
2026
Q2
$286K Sell
11,509
-12,796
-53% -$300K ﹤0.01% 2834
2026
Q1
$341K Buy
24,305
+4,641
+24% +$62.5K ﹤0.01% 2521
2025
Q4
$221K Sell
19,664
-20,294
-51% -$232K ﹤0.01% 2582
2025
Q3
$462K Buy
39,958
+17,759
+80% +$208K ﹤0.01% 2025
2025
Q2
$272K Buy
+22,199
New +$279K ﹤0.01% 2208
2024
Q4
– Sell
-10,600
Closed -$255K – 2432
2024
Q3
$255K Buy
+10,600
New +$242K ﹤0.01% 2174
2023
Q2
– Sell
-421
Closed -$607K – 1661
2023
Q1
$607K Buy
+421
New +$12.2K ﹤0.01% 1200

Other funds holding AVNS

Cerity Partners's AVNS Position: Q3 2026 in Review

Cerity Partners sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 11,509 shares — an estimated $286K sold.

Cerity Partners first reported a position in AVNS in Q1 2023 and held it in 7 quarters. The position peaked at $607K in Q1 2023. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Cerity Partners reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Cerity Partners sold 11,509 Avanos Medical shares in Q3 2026, an estimated $286K.
  • Cerity Partners first reported a position in Avanos Medical in Q1 2023 and held it in 7 quarters.
  • Cerity Partners's Avanos Medical position peaked at $607K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.